• VapeBiz
  • Tobacco
  • PMIs heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products

PMIs heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products

Share on facebook
Share on twitter
Share on linkedin
Share on reddit
Share on whatsapp
Share on pinterest
"Importance Philip Morris International (PMI) is seeking the Food and Drug Administration’s (FDA) authorization to market IQOS as a modified risk tobacco product and making marketing claims of reduced risk and reduced exposure. Such claims may be misunderstood by youth, thereby increasing their risk for tobacco initiation."
Heat-tabacco-product

Abstract

Importance Philip Morris International (PMI) is seeking the Food and Drug Administration’s (FDA) authorization to market IQOS as a modified risk tobacco product and making marketing claims of reduced risk and reduced exposure. Such claims may be misunderstood by youth, thereby increasing their risk for tobacco initiation.

Objective To assess youth (mean age 19.3, SD=1.7) understanding and perceptions of PMI’s proposed consumer marketing claims of reduced risk and reduced exposure, we embedded a randomized controlled experiment into a survey of 450 California youth (April to August 2018). Participants were randomized to see ‘reduced exposure,’ ‘reduced risk’ or neither claim. Perceptions of IQOS-related health risks and general harm and understanding of the term ‘switching completely’ as used in PMI’s proposed claims were compared.

Results Mean expectancies to experience specific health risks did not differ by claim exposure. The reduced exposure group’s perceptions of general harm did not differ from those of controls nor from the reduced risk group. The reduced risk group had the largest proportion who perceived IQOS as moderately/less harmful (n=78, 52%); controls the largest proportion perceiving IQOS as quite/extremely harmful (n=91, 63%). While 71% of the sample understood the term ‘switch completely’ correctly as used in the reduced risk (n=194, 71%) and reduced exposure (n=206, 72%) claims, more than 1 in 4 did not.

Conclusions FDA and other regulators must use caution when considering allowing claims of reduced risk or reduced exposure to appear on retail tobacco packaging. Youth misunderstand such claims, and misperceptions of harm are known to lead to tobacco-use initiation.

© 2019-2020 VAPEBIZ.NET All Rights Reserved. Content Can Not Be Translated or Reproduced without Authorization.
David@Vapebiz.net

Related Articles

0 0 vote
Article Rating
Subscribe
Notify of
guest
Your Name
Your Email
0 Comments
Inline Feedbacks
View all comments